EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Species barriers in AAV tropism: mechanisms, models, and emerging solutions for clinical translation

Xinyuan Xu

Acta Biochimica Polonica · 26.03.2026 · 73

DOI: 10.3389/abp.2026.15939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biochimica Polonica, online erschienen am 26.03.2026. Verfasst von Xinyuan Xu. Beteiligte Einrichtung: Postdoctoral Research Workstation, Beijing State-owned Capital Operation and Management Company Limited, Beijing, China. Hauptthemen laut MEDLINE: Dependovirus, Viral Tropism, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adeno-associated virus (AAV) vectors have become central to in vivo gene therapy across genetic and acquired diseases. Yet despite extensive preclinical validation, AAV programs often encounter translational gaps when advancing from rodents to non-human primates (NHPs) and ultimately to humans. These species barriers arise from differences in capsid–receptor interactions, intracellular trafficking, immune landscapes, and tissue microanatomy. Even within species, strain-level genetic variation can markedly alter vector performance, exemplified by the LY6A-dependent central nervous system (CNS) tropism of AAV-PhP.B in C57BL/6J mice. Old world monkeys, which are evolutionarily closer to humans than new world species, remain the most widely used models for systemic and CNS delivery, yet discrepancies in seroprevalence, complement activity, endothelial biology, and neuronal susceptibility still limit predictability. Recent advances, including machine learning–guided capsid design, deep mutational scanning, and human-derived organoids and explant models, offer powerful tools to bridge these barriers. This mini-review synthesizes current understanding of AAV species barriers and outlines strategies that enhance the robustness and human relevance of AAV gene therapy development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusViral TropismGenetic TherapyGenetic VectorsAnimalsHumansSpecies SpecificityMiceTranslational Research, Biomedical

Stichwörter der Autor:innen

AAVAIgene therapyspecies differencetropism

Autor:innen und Institutionen

  • Postdoctoral Research Workstation, Beijing State-owned Capital Operation and Management Company Limited, Beijing, China.

Zitieren

APA

Xu, X. (2026). Species barriers in AAV tropism: mechanisms, models, and emerging solutions for clinical translation. Acta Biochimica Polonica, 73. https://doi.org/10.3389/abp.2026.15939

Vancouver

Xu X. Species barriers in AAV tropism: mechanisms, models, and emerging solutions for clinical translation. Acta Biochimica Polonica. 2026;73. doi:10.3389/abp.2026.15939

BibTeX
@article{Xu2026,
  author = {Xu, Xinyuan},
  title = {Species barriers in AAV tropism: mechanisms, models, and emerging solutions for clinical translation},
  journal = {Acta Biochimica Polonica},
  year = {2026},
  volume = {73},
  doi = {10.3389/abp.2026.15939}
}
Kostenlos starten →